Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar:109:29-31.
doi: 10.1016/j.jhin.2020.11.030. Epub 2020 Dec 15.

Impact of SARS CoV-2 pandemic on carbapenemase-producing Klebsiella pneumoniae prevention and control programme: convergent or divergent action?

V Belvisi  1 , C Del Borgo  2 , S Vita  3 , P Redaelli  4 , P Dolce  5 , D Pacella  5 , B Kertusha  6 , A Carraro  4 , R Marocco  2 , M De Masi  2 , C Mastroianni  4 , M Lichtner  6 ; IPC Program Working Group
Collaborators, Affiliations

Impact of SARS CoV-2 pandemic on carbapenemase-producing Klebsiella pneumoniae prevention and control programme: convergent or divergent action?

V Belvisi et al. J Hosp Infect. 2021 Mar.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Indexes of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-Kp) colonization in the intensive care unit (ICU). (a) Point prevalence: a Poisson regression model shows an overall trend of decrease since the beginning of the programme in April 2019 to last observations in June 2020 (P<0.001), with a relative statistically significant increase in the early COVID-19 pandemic period (encircled in the figure) (P<0.001) which did not affect this trend. (b) Incidence density rate: a Poisson regression model (considering the total hospitalization days as an offset in the model) shows that the multimodal prevention programme maintains its objective: a statistically significant overall decrease in trend was observed since the beginning to the last month of observation in June 2020 (P=0.0123), with the only exception of April 2020 as a non-significant outlier in the encircled period January–May 2020 (P=0.374).
See this image and copyright information in PMC

References

    1. Gasink L.B., Edelstein P.H., Lautenbach E., Synnestvedt M., Fishman N.O. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase–producing K. pneumoniae. Infect Control Hosp Epidemiol. 2009;30:1180–1185. - PMC - PubMed
    1. Gentile B., Grottola A., Orlando G., Serpini G.F., Venturelli C., Meschiari M. A retrospective whole-genome sequencing analysis of carbapenem and colistin-resistant Klebsiella pneumoniae nosocomial strains isolated during an MDR surveillance program antibiotics. Basel) 2020;9:246. - PMC - PubMed
    1. Distante C., Piscitelli P., Miani A. Covid-19 outbreak progression in Italian regions: approaching the peak by the end of March in Northern Italy and first week of April in Southern Italy. Int J Environ Res Public Health. 2020;17:3025. - PMC - PubMed
    1. Siegel J.D., Rhinehart E., Jackson M., Chiarello L. Management of multidrug-resistant organisms in health care settings. Am J Infect Control. 2007;35:165–193. - PubMed
    1. Friedman N.D., Carmeli Y., Walton A.L., Schwaber M.J. Carbapenem-resistant Enterobacteriaceae: a strategic roadmap for infection control. Infect Control Hosp Epidemiol. 2017;38:580–594. - PubMed

MeSH terms